Meyka AI API is live for developers.Start building.
Advertisement
Scilex Holding Company

Scilex Holding Company Fundamental Analysis

SCLXNASDAQ
HealthcareDrug Manufacturers - General
$7.00
$0.58(7.65%)
U.S. Market opens in 52h 48m
Advertisement

Scilex Holding Company Fundamental Analysis

Scilex Holding Company (SCLX) shows moderate financial fundamentals with a PE ratio of -0.11, profit margin of -12.39%, and ROE of 1.90%. The company generates $0.0B in annual revenue with strong year-over-year growth of 21.07%.

Key Strengths

PEG Ratio0.00

Areas of Concern

ROE1.90%
Operating Margin-8.17%
Current Ratio0.08
We analyze SCLX's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -866.3/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-866.3/100

We analyze SCLX's fundamental strength across five key dimensions:

Efficiency Score

Weak

SCLX struggles to generate sufficient returns from assets.

ROA > 10%
-1.43%

Valuation Score

Excellent

SCLX trades at attractive valuation levels.

PE < 25
-0.11
PEG Ratio < 2
0.00

Growth Score

Excellent

SCLX delivers strong and consistent growth momentum.

Revenue Growth > 5%
21.07%
EPS Growth > 10%
56.68%

Financial Health Score

Moderate

SCLX shows balanced financial health with some risks.

Debt/Equity < 1
-0.43
Current Ratio > 1
0.08

Profitability Score

Weak

SCLX struggles to sustain strong margins.

ROE > 15%
190.13%
Net Margin ≥ 15%
-12.39%
Positive Free Cash Flow
No

Key Financial Metrics

Is SCLX Expensive or Cheap?

P/E Ratio

SCLX trades at -0.11 times earnings. This suggests potential undervaluation.

-0.11

PEG Ratio

When adjusting for growth, SCLX's PEG of 0.00 indicates potential undervaluation.

0.00

Price to Book

The market values Scilex Holding Company at -0.19 times its book value. This may indicate undervaluation.

-0.19

EV/EBITDA

Enterprise value stands at 0.12 times EBITDA. This is generally considered low.

0.12

How Well Does SCLX Make Money?

Net Profit Margin

For every $100 in sales, Scilex Holding Company keeps $-12.39 as profit after all expenses.

-12.39%

Operating Margin

Core operations generate -8.17 in profit for every $100 in revenue, before interest and taxes.

-8.17%

ROE

Management delivers $1.90 in profit for every $100 of shareholder equity.

1.90%

ROA

Scilex Holding Company generates $-1.43 in profit for every $100 in assets, demonstrating efficient asset deployment.

-1.43%

Following the Money - Real Cash Generation

Operating Cash Flow

Scilex Holding Company generates limited operating cash flow of $-4.57M, signaling weaker underlying cash strength.

$-4.57M

Free Cash Flow

Scilex Holding Company generates weak or negative free cash flow of $-8.12M, restricting financial flexibility.

$-8.12M

FCF Per Share

Each share generates $-0.96 in free cash annually.

$-0.96

FCF Yield

SCLX converts -11.00% of its market value into free cash.

-11.00%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.11

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.001

vs 25 benchmark

P/B Ratio

Price to book value ratio

-0.19

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.73

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-0.43

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.08

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

1.90

vs 25 benchmark

ROA

Return on assets percentage

-1.43

vs 25 benchmark

ROCE

Return on capital employed

1.33

vs 25 benchmark

How SCLX Stacks Against Its Sector Peers

MetricSCLX ValueSector AveragePerformance
P/E Ratio-0.1129.20 Better (Cheaper)
ROE190.13%729.00% Weak
Net Margin-1239.37%-52856.00% (disorted) Weak
Debt/Equity-0.430.49 Strong (Low Leverage)
Current Ratio0.084.43 Weak Liquidity
ROA-142.92%-20711.00% (disorted) Weak

SCLX outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Scilex Holding Company's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

56.02%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

76.36%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

118.57%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ